



TRILEPTAL vs carbamazepine (CBZ):
different molecule, different metabolite

|
|
View the animation Chemical Differences in Trileptal.
The animated demonstration will appear in a new browser window. Close the window after you have finished viewing the animation.
Differences in mechanisms of action
 |
TRILEPTAL and CBZ may have different affinities for sodium (Na+) channels1 |
 |
TRILEPTAL and CBZ have different effects on calcium channels2
 |
TRILEPTAL acts on N- and P-type calcium channels |
 |
CBZ acts on L-type calcium channels |
 |
Activity at these ion channels may contribute to anticonvulsant effects |
|
Different clinical profile delivers enhanced safety and ease of use
| |
TRILEPTAL® |
Carbamazepine3 |
| Black box warning |
No |
Yes (aplastic anemia, agranulocytosis) |
| Required monitoring of CBC/LFT |
No |
Yes |
| Primary metabolic pathway |
Reduction |
Oxidation via CYP450 enzymes |
Potential interactions with common medications
– Erythromycin
– Warfarin
– Cimetidine
– Oral contraceptives
|
No No No Yes |
Yes Yes Yes Yes |
| Protein binding |
Low (40%) |
Moderate (76%) [50% epoxide]3 |
| Kinetics |
Linear |
Autoinduction/Linear |
Of patients who have had hypersensitivity to carbamazepine, 25% to 30% will experience a reaction to oxcarbazepine. Caution should be exercised when prescribing TRILEPTAL for patients with a history of hypersensitivity to carbamazepine. (Please see WARNINGS section of complete prescribing information.)
References:
|